QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,500 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Mr. Douglas Bryant 2009 'den beri şirketle birlikte olan QuidelOrtho Corp 'in President 'ıdır.
QDEL hissesinin fiyat performansı nasıl?
QDEL 'in mevcut fiyatı $11.89 'dir, son işlem günde 3.22% azalmış etti.
QuidelOrtho Corp için ana iş temaları veya sektörler nelerdir?
QuidelOrtho Corp Health Care endüstrisine ait ve sektör Health Care 'dir
QuidelOrtho Corp 'in piyasa değerlemesi nedir?
QuidelOrtho Corp 'in mevcut piyasa değerlemesi $809.7M 'dir
QuidelOrtho Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 8 analist QuidelOrtho Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 6 al, 4 tut, 1 sat ve 4 güçlü sat içermektedir